FULC
Fulcrum Therapeutics Inc
3.70$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | |
| – | – | 273.7% | 27.0% | 13.1% | 1,210.7% | 2,559.8% | 79.2% | – | |
| – | – | -273.7% | 100.0% | 100.0% | -1,110.7% | -2,459.8% | 20.8% | – | |
| – | – | 9,476.3% | 669.2% | 363.7% | 1,210.7% | 2,559.8% | 79.2% | – | |
| – | – | 1,752.7% | 242.5% | 159.2% | 657.4% | 1,395.8% | 43.7% | – | |
| – | – | 11,228.9% | 911.6% | 523.0% | 664.2% | 1,485.5% | 48.1% | – | |
| – | – | -11,228.9% | -811.6% | -423.0% | -1,774.9% | -3,945.2% | -27.4% | – | |
| – | – | 0.0% | 0.0% | 14.2% | 42.4% | – | – | – | |
| – | – | -11,023.6% | -802.7% | -421.9% | -1,732.4% | -3,470.1% | -12.2% | – | |
| – | – | -475.2% | -27.0% | -13.1% | -67.0% | 71.4% | – | – | |
| – | – | -10,548.4% | -775.7% | -408.8% | -1,732.4% | -3,470.1% | -12.2% | – | |
| – | – | -10,955.2% | -784.7% | -409.8% | -1,730.1% | -3,392.6% | -22.8% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.